(dollars in thousands)	January 31, 2021		February 2, 2020			May 3, 2020
Tradename	$	540	$	4,804		$	540
Customer relationships, net		2,012		2,313			2,238
Non-compete agreement, net		546		621			602
	$	3,098	$	7,738	(1)	$	3,380

	Nine months ended
(dollars in thousands)	January 31, 2021		February 2, 2020
Beginning balance	$	540	$	7,232
Asset impairment charge - discontinued operation		—		(2,428	)
Ending balance	$	540	$	4,804

Our tradename totaling $540,000 as of January 31, 2021, pertained to Read, a separate reporting unit within the upholstery fabrics segment. This tradename was determined to have an indefinite useful life at the time of its acquisition, and therefore, is not being amortized. However, we are required to assess this tradename annually or between annual tests if we believe indicators of impairment exist. Based on our assessment as of January 31, 2021, no indicators of impairment existed and therefore, no asset impairment charges associated with our tradename were recorded through the third quarter of fiscal 2021.

As of February 2, 2020, we believed indicators of impairment existed that pertained to the future outlook of our former home accessories reporting unit and its slower than expected business improvement, as well as economic conditions that existed within the e-commerce bedding space. Since we determined it was more-likely-than-not that the fair value of the tradename associated with our former home accessories reporting unit was less than its carrying amount, we performed a quantitative impairment test. Our quantitative impairment test involved determining the fair value of the tradename associated with of our former home accessories reporting unit utilizing a relief from royalty method and comparing the respective fair value with its respective carrying amount. Consequently, based on our quantitative impairment test, we recorded an asset impairment charge totaling $2.4 million that is presented within the caption titled “loss before income taxes discontinued operation” in the consolidated statements of net income (loss) for the three-month and nine-month periods ended February 2, 2020.

During the fourth quarter of fiscal 2020, management made a strategic decision to sell our entire ownership in eLuxury to focus on our core products of mattress and upholstery fabrics, which we believed would increase our liquidity and assist with our comprehensive response to the COVID-19 global pandemic. As a result, we recorded an additional impairment charge of $4.2 million based on the expected selling price of our entire ownership in eLuxury compared with its carrying amount. As disclosed in Note 3 of the consolidated financial statements, effective March 31, 2020, we sold our entire ownership in eLuxury to its former noncontrolling interest holder, resulting in the elimination of the home accessories segment at such time. Based on the terms of the sale agreement, we did not receive any consideration for eLuxury’s net assets that were associated with the sale of our entire ownership interest in eLuxury. The $4.2 million asset impairment charge recorded during the fourth quarter of fiscal 2020 was presented within the discontinued operation section of our fiscal 2020 consolidated statement of net loss reported in our fiscal 2020 Form 10-K.

As of May 3, 2020, we performed our annual assessment for impairment of Read’s tradename and believed indicators of impairment existed, such as our unfavorable financial performance and the significant decline in the price per share of our common stock and market capitalization stemming from the COVID-19 global pandemic. As a result, we determined it was more-likely-than-not that the fair value of Read’s tradename was less than its carrying amount, and in turn, we performed a quantitative impairment test. Our quantitative impairment test involved determining the fair value of Read’s tradename utilizing the relief from royalty method and comparing the respective fair value of Read’s tradename with its carrying amount. Consequently, based on our quantitative impairment test, we recorded an asset impairment charge of $143,000 in the asset impairments financial statement line item in the fiscal 2020 consolidated statement of net loss reported in our fiscal 2020 Form 10-K.

A summary of the change in the carrying amount of our customer relationships follows:

	Nine months ended
(dollars in thousands)	January 31, 2021			February 2, 2020
Beginning balance	$	2,238		$	2,538
Amortization expense		(226	)		(225	)
Ending balance	$	2,012		$	2,313

Our customer relationships are amortized on a straight-line basis over useful lives ranging from nine to seventeen years.

The gross carrying amount of our customer relationships was $3.1 million as of January 31, 2021, February 2, 2020, and May 3, 2020, respectively. Accumulated amortization for these customer relationships was $1.1 million, $802,000, and $877,000 as of January 31, 2021, February 2, 2020, and May 3, 2020, respectively.

The remaining amortization expense for the next five fiscal years and thereafter follows: FY 2021 - $76,000; FY 2022 - $301,000; FY 2023 - $301,000; FY 2024 - $301,000; FY 2025 - $301,000; and thereafter - $732,000.

The weighted average amortization period for our customer relationships is 6.9 years as of January 31, 2021.

A summary of the change in the carrying amount of our non-compete agreement follows:

	Nine months ended
(dollars in thousands)	January 31, 2021			February 2, 2020
Beginning balance	$	602		$	678
Amortization expense		(56	)		(57	)
Ending balance	$	546		$	621

Our non-compete agreement is amortized on a straight-line basis over the fifteen year life of the agreement.

The gross carrying amount of our non-compete agreement was $2.0 million as of January 31, 2021, February 2, 2020, and May 3, 2020, respectively. Accumulated amortization for our non-compete agreement was $1.5 million as of January 31, 2021, $1.4 million as of February 2, 2020, and $1.4 million as of May 3, 2020.

The remaining amortization expense for the next five years and thereafter follows: FY 2021 - $18,000; FY 2022 - $76,000; FY 2023 - $76,000; FY 2024 - $76,000; FY 2025 - $76,000, and thereafter - $224,000.

The weighted average amortization period for the non-compete agreement is 7.3 years as of January 31, 2021.